Navigation Links
Epilepsy Found to Be More Common in U.S. Than Thought
Date:12/28/2010

By Steven Reinberg
HealthDay Reporter

MONDAY, Dec. 27 (HealthDay News) -- A new study suggests that one of every 26 people in the United States will develop epilepsy at some point in their life.

That's a higher rate than previously believed and, experts say, highlights the need for more funding and attention to the condition.

"This study is an important analysis of the potential number of patients of epilepsy in the United States," said Dr. Joseph I. Sirven, the chairman-elect of the Epilepsy Foundation's professional advisory board and a professor and chairman of neurology at the Mayo Clinic in Scottsdale, Ariz.

Sirven, who was not involved in the study, noted that it makes two important points:

  • Older adults are more at risk for developing epilepsy.
  • A greater number of people will develop epilepsy during their lifetime than thought.

"The study suggests up to 12 million Americans will develop epilepsy, which is a greater number than expected," Sirven said. "Moreover, this is a conservative estimate and not the worst case scenario as the lifetime risk would be higher in more urban areas. Clearly, more attention needs to be paid to this condition."

The findings are published in the Jan. 4 issue of Neurology.

For the study, Dale C. Hesdorffer, an associate professor of clinical epidemiology at Sergievsky Center at Columbia University Medical Center in New York City, and her research colleagues looked for the likelihood of developing epilepsy among residents of Rochester, Minn., between 1960 and 1979.

They identified 412 people with the disease during that period and calculated the lifetime risk of developing epilepsy at 1.6 percent up to age 50 and 3 percent up to age 80.

Over the years, the lifetime risk increased from 3.5 percent in the 1960-1969 time frame to 4.2 percent for 1970 to 1979, the researchers found.

"Our results highlight the need for more research using epilepsy surveillance data, especially given the aging population in the United States," Hesdorffer said in a news release from the American Academy of Neurology. "Such surveillance will also provide useful information for health-care planners as they address the service needs of people with epilepsy."

Dr. Edwin Trevathan, dean of the St. Louis University School of Public Health and author of an accompanying editorial in the journal, said that epilepsy largely goes unnoticed, with only limited data on new cases.

"As a result, we do not have good data to inform decisions made by our health leaders, and some of our best researchers are analyzing data that are 30 to 50 years old," Trevathan said in the news release.

He urged additional congressional funding so that the U.S. Centers for Disease Control and Prevention can collect needed data.

"Epilepsy has a major impact on public health," Trevathan said. "A national approach to monitoring epilepsy trends is desperately needed in order to monitor the impact of improvements in epilepsy care, to identify problems with epilepsy care that need to be corrected and to provide up-to-date data for researchers."

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on epilepsy.

SOURCES: Joseph I. Sirven, M.D., chairman-elect, professional advisory board, Epilepsy Foundation, and professor and chairman, department of neurology, Mayo Clinic, Scottsdale, Ariz.; Dec. 27, 2010, news release, American Academy of Neurology; Jan. 4, 2011, Neurology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers: Pay more attention to epilepsy
2. Death Rates Higher for Those With Lasting Epilepsy: Study
3. Common Epilepsy Drug Taken During Pregnancy Might Raise Spina Bifida Risk
4. Women Taking Certain Epilepsy Drugs Can Safely Breast-Feed, Study Suggests
5. Study Sees Link Between Epilepsy, Infertility
6. Great strides in treatment of stroke, headache, epilepsy
7. Epilepsy Drugs Dont Raise Suicide Risk, Study Shows
8. Not All Epilepsy Drugs Raise Suicide Risk: Study
9. Brain Injury May Raise Soldiers Epilepsy Risk
10. FDA accepts historical controls for epilepsy monotherapy studies
11. Study confirms favorable long-term prognosis of epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Epilepsy Found to Be More Common in U.S. Than Thought
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Over 40 ... convened in the state capitol for the annual “Hike to Harrisburg” advocacy day. ... and The Winter Group, PATS lobby Group. The goal for the day was ...
(Date:5/4/2016)... ... ... , a leading provider of barcode and RFID labels has acquired ... to continue to grow its label business, customer base and market share. , Netc ... print and label tape media on site and on an as needed basis. Many of ...
(Date:5/3/2016)... ... May 03, 2016 , ... ProIntro Glitch is a set of ... Film Studios’ titles allow users to add a terrifying opener to any video or ... lines and accents. To add greater contrast, all the user has to do is ...
(Date:5/3/2016)... ... May 03, 2016 , ... Sue Desmond-Hellmann, chief executive officer ... to stretch the limits of human possibility in her keynote address at Georgia State ... Georgia Dome. , Drawing on her rich experience as a scientist, physician and executive, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Calvary Hospital recently hosted a reception to ... a 10-bed unit located at Mary, Manning Walsh Home (MMW) in Manhattan. , ... DGH for half an hour, once a week. The music brings a lot of ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: